Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?

✍ Scribed by Sergio Rizzo; Giuseppe Bronte; Daniele Fanale; Lidia Corsini; Nicola Silvestris; Daniele Santini; Gaspare Gulotta; Viviana Bazan; Nicola Gebbia; Fabio Fulfaro; Antonio Russo

• Book ID: 117487895
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 227 KB
• Volume: 36
• Category: Article
• ISSN: 0305-7372
• DOI: 10.1016/s0305-7372(10)70021-9